Peptide therapy, prescribed — not bought off a label.
Independent licensed physicians.
Licensed U.S. pharmacies.
Your health history is reviewed online by a physician licensed in your state. When it’s appropriate, they prescribe, and a licensed U.S. pharmacy dispenses. Provider-guided wellness, built compliance-first.
Ever.
Prescription peptide therapy, handled properly.
We don’t put a menu on the homepage. What’s right for you is a decision for a licensed physician, made after reviewing your health history, not a product you pick off a list.
- 01
Physician first
A physician licensed in your state reviews your history online and decides whether a prescription is appropriate. Not everyone qualifies.
- 02
Licensed U.S. pharmacy
When prescribed, your medication is prepared by a licensed U.S. pharmacy and shipped to your door.
- 03
Never “research use only”
No gray-market or research-grade vials. If it can’t be legally dispensed, we don’t offer it.
Vial shown is an illustration, not a product. People in the videos are models, not patients. A licensed physician decides whether any treatment is appropriate; not everyone qualifies. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety or effectiveness. Currently waitlist only. Nothing here is medical advice.
From waitlist to your door, with a physician at every decision.
What our physicians evaluate.
Each area starts with a physician review. Nothing is prescribed unless it’s clinically appropriate for you and can be legally dispensed today.
Status reflects current U.S. regulation as tracked in our news coverage. Availability varies by state and is confirmed at launch in each state. Nothing on this page is medical advice.
What we look for before a pharmacy fills a prescription.
This week in peptides.
The Political Push for Faster Peptide Access Collides With a Sterility Recall
A senator wants faster peptide access. A licensed pharmacy just recalled vials over a sterility gap. This week showed how far apart peptide policy and peptide practice still are. On October 20…
A Peptide Compounding Policy Reaches the White House, as a New Investigation Surfaces Patient-Harm Reports
Regulators are easing peptide rules. Patients are describing migraines, numbness, and panic attacks. A policy that would let compounding pharmacies make some popular peptides is now sitting with the White House for…
What a Biologic Ruling Would Actually Change, and the Bigger Compounding Vote Already Taking Shape
Twelve years vs. five: the exclusivity gap one pending ruling could open for a weight-loss drug. It was a quiet week for new rulings or warning letters — but two pieces of…
Frequently asked.
Launching in all 50 states. Be first in line.
Join the waitlist and we’ll notify you the moment physician-guided care opens. No health information needed to join.
Reserve your place for physician-guided care.
Joining takes a minute and asks for no health information. Your online health intake happens later, securely, once care opens in your state.
- Early access by stateWe notify waitlist members first as each state opens.
- Independent licensed physiciansEvery plan is reviewed and prescribed by a physician licensed in your state.
- The weekly news briefOur plain-English read on peptide regulation and safety, if you want it.